Premedication With Intranasal Dexmedetomidine or Midazolam for Prevention of Emergence Agitation in Children

• Status: Completed
• Trial end date: 2018-01-15
• Target enrollment: 0
• Participant gender: All

Summary

Study where children will receive one premedication, either intranasal dexmedetomidine or oral midazolam, to reduce agitation on emergence of anesthesia. The hypothesis is that dexmedetomidine is superior but previous studies lack quality.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Brasilia University Hospital
• Treatments: Dexmedetomidine; Midazolam; Pharmaceutical Solutions

Criteria

Inclusion Criteria:

• Scheduled for amygdalectomy

• American Society of Anesthesiologists Physical Status PI or PII

• Absence of congenital neuropathy

• Absence of cardiac pathology (any)

• Intolerance to one of the studied drugs.

Exclusion Criteria:

• Protocol violation

• Need to transfer for ICU intubated